5-fluorotryptamine has been researched along with indalpine in 1 studies
| Studies (5-fluorotryptamine) | Trials (5-fluorotryptamine) | Recent Studies (post-2010) (5-fluorotryptamine) | Studies (indalpine) | Trials (indalpine) | Recent Studies (post-2010) (indalpine) |
|---|---|---|---|---|---|
| 15 | 0 | 4 | 74 | 9 | 1 |
| Protein | Taxonomy | 5-fluorotryptamine (IC50) | indalpine (IC50) |
|---|---|---|---|
| Sodium-dependent serotonin transporter | Homo sapiens (human) | 0.03 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Böttcher, H; Greiner, HE; Harting, J; Matzen, L; Rautenberg, W; Seyfried, CA; van Amsterdam, C | 1 |
1 other study(ies) available for 5-fluorotryptamine and indalpine
| Article | Year |
|---|---|
5-HT reuptake inhibitors with 5-HT(1B/1D) antagonistic activity: a new approach toward efficient antidepressants.
Topics: Animals; Antidepressive Agents; Brain; Corpus Striatum; Frontal Lobe; Guinea Pigs; Hippocampus; In Vitro Techniques; Indoles; Muscle Contraction; Muscle, Smooth, Vascular; Rabbits; Radioligand Assay; Rats; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Saphenous Vein; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Synaptosomes | 2000 |